MiR-660-5p was upregulated in all metastatic cell lines (BoM, BrM, LnM, LuM), and remarkably promoted NSCLC progression and distant metastasis both in vitro and in vivo by targeting LIMCH1, SMARCA5, and TPP2. Here, TPP2 is linked to non-small cell lung carcinoma.